BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 2428948)

  • 1. VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors.
    Bosl GJ; Gluckman R; Geller NL; Golbey RB; Whitmore WF; Herr H; Sogani P; Morse M; Martini N; Bains M
    J Clin Oncol; 1986 Oct; 4(10):1493-9. PubMed ID: 2428948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors.
    Bosl GJ; Geller NL; Vogelzang NJ; Carey R; Auman J; Whitmore WF; Herr H; Morse M; Sogani P; Chan E
    J Clin Oncol; 1987 Mar; 5(3):436-40. PubMed ID: 2434627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum for advanced germ cell testis tumors: Brazilian experience.
    Srougi M; Simon SD; de Góes GM
    J Urol; 1985 Jul; 134(1):65-9. PubMed ID: 2409300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chemotherapeutic effectiveness in malignant testicular tumors at advanced stages. Preliminary results of the VAB VI program].
    Chiricuţă I; Ghilezan N
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1985; 34(6):455-68. PubMed ID: 2421373
    [No Abstract]   [Full Text] [Related]  

  • 5. The results of chemotherapy for extragonadal germ-cell tumors in the cisplatin era: the Memorial Sloan-Kettering Cancer Center experience (1975 to 1982).
    Israel A; Bosl GJ; Golbey RB; Whitmore W; Martini N
    J Clin Oncol; 1985 Aug; 3(8):1073-8. PubMed ID: 2410574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [VAB-6 combination chemotherapy in patients with stage II, III testicular tumor].
    Hida S; Kawakita M; Takenawa J; Fukuzawa S; Okuno H; Yamauchi T; Oishi K; Nishio Y; Takeuchi H; Okada K
    Hinyokika Kiyo; 1986 Dec; 32(12):1849-58. PubMed ID: 2435134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VAB-5 combination chemotherapy in prognostically poor risk patients with germ cell tumors.
    Vugrin D; Whitmore WF; Golbey RB
    Cancer; 1983 Mar; 51(6):1072-5. PubMed ID: 6185211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VAB-6 combination chemotherapy in resected stage II-B testis cancer.
    Vugrin D; Whitmore WF; Herr HW; Sogani P; Golbey RB
    Cancer; 1983 Jan; 51(1):5-8. PubMed ID: 6185195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy of disseminated germ cell tumors of the testis].
    Tiuliandin SA
    Sov Med; 1987; (11):78-81. PubMed ID: 2451298
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapy for germ cell tumors.
    Motzer RJ; Bosl GJ
    Urol Clin North Am; 1987 May; 14(2):389-98. PubMed ID: 2437682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preliminary evaluation of the toxicity and effectiveness of chemotherapy using the VAB-6 protocol in the treatment of non-seminoma of the testis].
    Madej G; Gigier A; Siedlecki P; Pieńkowski T
    Nowotwory; 1987; 37(1):44-9. PubMed ID: 2442730
    [No Abstract]   [Full Text] [Related]  

  • 12. [Results of chemotherapy in patients with disseminated testicular tumors].
    Abdyldaev TA; Tiuliandin SA; Batov SV
    Vopr Onkol; 1990; 36(1):85-9. PubMed ID: 1689527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Infusion of high doses of platidiam in the treatment of patients with germ cell testicular tumors].
    Tiuliandin SA
    Vopr Onkol; 1990; 36(1):89-92. PubMed ID: 1689528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum combination chemotherapy in metastatic testis cancer--a 1-year program.
    Vugrin D; Whitmore WF; Golbey RB
    J Urol; 1982 Dec; 128(6):1205-8. PubMed ID: 6185697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors.
    Bosl GJ; Geller NL; Bajorin D; Leitner SP; Yagoda A; Golbey RB; Scher H; Vogelzang NJ; Auman J; Carey R
    J Clin Oncol; 1988 Aug; 6(8):1231-8. PubMed ID: 2457657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VAB-3 combination chemotherapy in primary mediastinal germ cell tumors.
    Vugrin D; Martini N; Whitmore WF; Golbey RB
    Cancer Treat Rep; 1982 Jun; 66(6):1405-7. PubMed ID: 6177411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advanced non-seminoma germinal tumors of the testicle. Therapeutic strategy and method of action of chemotherapy].
    Bassoulet J; Raoul Y; Garetta L
    Ann Urol (Paris); 1986; 20(1):35-42. PubMed ID: 2423016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Total remission of advanced cancer of the testis with the use of the VAB6 schedule: experience with 40 cases].
    Srougi M; Simon SD; de Góes GM
    AMB Rev Assoc Med Bras; 1985; 31(3-4):52-8. PubMed ID: 2417287
    [No Abstract]   [Full Text] [Related]  

  • 19. Reassessment of the role of adjunctive surgical therapy in the treatment of advanced germ cell tumors.
    Carter GE; Lieskovsky G; Skinner DG; Daniels JR
    J Urol; 1987 Dec; 138(6):1397-401. PubMed ID: 2446018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of a 7-day delay in chemotherapy cycles on complete response and event-free survival in good-risk disseminated germ cell tumor patients.
    Motzer RJ; Geller NL; Bosl GJ
    Cancer; 1990 Sep; 66(5):857-61. PubMed ID: 1696846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.